Updates on commercial insights and readiness plans for sozinibercept in wet AMD Opthea management to present in New York City on Tuesday, January 28 at 1:30 PM ET In-person events in Sydney on ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in ...

澳大利亚墨尔本和美国新泽西州普林斯顿 - 专注于开发视网膜疾病治疗方法的生物制药公司Opthea Limited (ASX/NASDAQ: OPT)在同行评审期刊《转化视觉科学与技术》上发表了其sozinibercept治疗糖尿病黄斑水肿 (DME)的1b期试验结果。该研究评估了sozinibercept与标准抗VEGF-A疗法aflibercept联合使用在持续性DME患者中的安全性和有效性。

Other stars in December included Orthocell (ASX:OCC), which was up 67% amid “outstanding” clinical trial results and expected ...

An announcement from Opthea Limited ( ($AU:OPT) ) is now available. Opthea Limited announced the publication of its Phase 1b ...

What is the current share price of NIB Holdings Limited (NHF)? NIB Holdings Limited's (NHF) current share price is $5.56. This constitutes a price movement of 0.54% when compared to the share price 7 ...

Chinese stocks face limited downside next year as the market has factored in trade tension risks, while domestic stimulus measures offer a buffer against any further selloff, according to Goldman ...

Keppel FELS Limited (Keppel FELS), a wholly-owned subsidiary of Keppel Offshore & Marine (Keppel O&M) has secured a contract from TS Offshore Limited (TS Offshore), to construct an ultra-high ...

Dr Baldwin has more than 25 years of experience working on therapeutic drug development programs for oncology and ophthalmic indications. She is the founder and chief innovation officer of Opthea, a ...

Presentation on Wednesday, January 15, 2025, 5:15 PM PT in San Francisco, California MELBOURNE, Australia and PRINCETON, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ:OPT, “Opthea ...